Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Non-toxic melanoma therapy by a novel tubulin-binding agent
International Journal of Cancer, 09/23/09
Aneja R et al. – Unlike currently available chemotherapeutics, EM011 is non–toxic to normal tissues and most importantly, does not cause any immunosuppression and neurotoxicity. The data thus warrant a clinical evaluation of EM011 for melanoma therapy.
Related Articles
Predicting response to IL-2 therapy for metastatic melanoma
Expert Review of Anticancer Therapy, 11/12/09
Relevance Score: 67%
Single-institution Outcome of High-dose Interleukin-2 (HD IL-2) Therapy for Metastatic Melanoma and Analysis of Favorable Response in Brain Metastases
Anticancer Research, 11/11/09
Relevance Score: 67%
A phase 2 clinical trial of nab-paclitaxel in previously treated and chemotherapy-naive patients with metastatic melanoma
Cancer, 11/09/09
Relevance Score: 67%
Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy
The Oncologist, 10/30/09
Relevance Score: 67%
Pegylated interferons: Prospects for the use in the adjuvant and palliative therapy of metastatic melanoma
European Journal of Cancer, 10/29/09
Relevance Score: 66%
Today in Dermatologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
JWA regulates melanoma metastasis by integrin alphaVbeta3 signaling
Oncogene, 12/04/09
Immunocryosurgery for basal cell carcinoma: results of a pilot, prospective, open-label study of cryosurgery during continued imiquimod application
Journal of the European Academy of Dermatology and Venereology, 12/02/09
Self-reported screening for skin cancer in Austria
European Journal of Dermatology, 12/02/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients
Cancer Prevention Research, 12/06/09
Efficacy of plasma vascular endothelial growth factor in monitoring first-line chemotherapy in patients with advanced non-small cell lung cancer
BMC Cancer, 12/06/09
Phase I study of fixed dose gemcitabine plus epirubicin in patients with advanced solid malignancies
American Journal of Clinical Oncology, 12/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


